Drugs / GEN1057
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06573294 | Aug 2024 → Apr 2026 | metastatic malignant neoplasm | Genmab | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GEN1057 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06573294 ↗ |
| Route | Intravenous | “Intravenous (IV) infusion” NCT06573294 ↗ |